AGL 5.60 Decreased By ▼ -0.18 (-3.11%)
ANL 8.90 Increased By ▲ 0.02 (0.23%)
AVN 76.85 Decreased By ▼ -2.07 (-2.62%)
BOP 5.26 Decreased By ▼ -0.02 (-0.38%)
CNERGY 4.63 Decreased By ▼ -0.07 (-1.49%)
EFERT 81.27 Decreased By ▼ -0.33 (-0.4%)
EPCL 50.08 Decreased By ▼ -0.83 (-1.63%)
FCCL 13.16 Decreased By ▼ -0.22 (-1.64%)
FFL 5.69 Decreased By ▼ -0.03 (-0.52%)
FLYNG 7.07 Decreased By ▼ -0.08 (-1.12%)
FNEL 4.79 Decreased By ▼ -0.03 (-0.62%)
GGGL 8.80 Decreased By ▼ -0.10 (-1.12%)
GGL 14.55 Decreased By ▼ -1.33 (-8.38%)
HUMNL 5.69 Decreased By ▼ -0.08 (-1.39%)
KEL 2.63 Decreased By ▼ -0.03 (-1.13%)
LOTCHEM 28.60 Decreased By ▼ -0.45 (-1.55%)
MLCF 24.49 Decreased By ▼ -0.61 (-2.43%)
OGDC 72.43 Decreased By ▼ -0.02 (-0.03%)
PAEL 15.36 Increased By ▲ 0.01 (0.07%)
PIBTL 5.00 Decreased By ▼ -0.05 (-0.99%)
PRL 16.10 Decreased By ▼ -0.19 (-1.17%)
SILK 1.08 Decreased By ▼ -0.01 (-0.92%)
TELE 9.14 Decreased By ▼ -0.23 (-2.45%)
TPL 7.23 Decreased By ▼ -0.10 (-1.36%)
TPLP 18.61 Decreased By ▼ -0.34 (-1.79%)
TREET 21.68 Decreased By ▼ -0.32 (-1.45%)
TRG 136.71 Decreased By ▼ -4.44 (-3.15%)
UNITY 16.88 Decreased By ▼ -0.14 (-0.82%)
WAVES 9.86 Decreased By ▼ -0.04 (-0.4%)
WTL 1.41 No Change ▼ 0.00 (0%)
BR100 4,225 Decreased By -29.6 (-0.7%)
BR30 15,518 Decreased By -214.7 (-1.36%)
KSE100 42,150 Decreased By -243.4 (-0.57%)
KSE30 15,588 Decreased By -75.7 (-0.48%)
Follow us

KARACHI: “People with diabetes, who are eager to fast, must consult with their doctor prior to the beginning of Ramazan and follow their medical advice,” said medical experts from Diabetes Task Force and Advice Academy while speaking at ‘Diabetes Management during Ramazan’, organized by Sanofi Pakistan.

They said fasting without following proper guidance could adversely affect the health of a person suffering from the chronic conditions such as diabetes. Greater awareness and adherence to scientific guidelines on this topic will make Ramazan a safer experience for people with diabetes.

Similarly, physicians should assess their patients’ ability to fast and advise accordingly. Patients must not place themselves at risk, as the decision to fast or not, should be based on medical advice, the speakers said, emphasizing that following a highly individualized management plan and close follow-up is essential to avoid the development of complications.

The panel of speakers comprised Prof Dr A H Aamir, Chairman Diabetes Task Force, KPK; Prof Dr Saeed A Mahar, Past President, Pakistan Endocrine Society (PES); Dr. S Abbas Raza, executive Committee member International Society of Endocrinology and Dr Faisal Masood Qureshi, executive member PES.

Patients do not always fully understand the implications of diabetes and the impact that fasting could have on their health. People often consume large quantities of unhealthy deep-fried, oily and sugary food items and beverages during Iftar that can lead to complications.

Patients should specifically ask their doctors about medication dosage and timing alteration, diet and fluid intake, physical activity, self-monitoring of blood glucose, and symptoms of low or high blood glucose that may necessitate breaking the fast in order to prevent damage or danger to their well-being. People with diabetes must perform regular blood sugar monitoring during Ramazan and focus on maintaining an appropriate diet in Sehar and Iftar for a safe fasting.

Copyright Business Recorder, 2022

Comments

Comments are closed.

Ramazan and diabetes: experts offer a piece of highly valuable advice to patients

‘Won’t take IMF’s dictation’: Dar

PTI quitting provincial assemblies will be humiliating for its voters: Saad Rafiq

Russia: price cap is ‘dangerous’ and will not curb demand for our oil

Pakistan calls on interim Afghan govt to up security at Kabul embassy after attack

US unveils high-tech B-21 stealth bomber

Zelenskiy’s chief of staff: Price cap on Russian oil should be lowered to $30 a barrel

Maj-Gen Sharif made ISPR DG

Azam knocks 100 as Pakistan reach 411-3 at tea in first Test

SBP repays $1bn bond before due date

FY22 trade with US soars 38.3pc to $10.5bn YoY, NA told